Could a common painkiller boost survival after a deadly aortic tear?
NCT ID NCT06968806
First seen Nov 17, 2025 · Last updated May 15, 2026 · Updated 21 times
Summary
This study tests whether the anti-inflammatory drug ketorolac can improve outcomes for 360 people undergoing emergency surgery for a severe aortic tear (Stanford Type A aortic dissection). Participants receive either ketorolac or a placebo before and after surgery, alongside standard care. Researchers will track deaths, organ failure, and other serious complications for up to 90 days. The goal is to see if reducing inflammation with ketorolac leads to better recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing Drum Tower Hospital
RECRUITINGNanjing, Jiangsu, 210008, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.